Extractive Spectrophotometric Determination of Omeprazole in Pharmaceutical Preparations by Bhandage, A et al.
Bhandage et al  
Trop J Pharm Res, October 2009; 8 (5):  449 
Tropical Journal of Pharmaceutical Research, October 2009; 8 (5): 449-454 
© Pharmacotherapy Group,  
Faculty of Pharmacy, University of Benin,  
Benin City, 300001 Nigeria.  
All rights reserved. 
 




Extractive Spectrophotometric Determination of 
Omeprazole in Pharmaceutical Preparations 
 
Amol Bhandage1, Ashok Bhosale1, Ashok Kasture2 and Vijaya 
Popatrao Godse1*  
1
Department of Pharmaceutical Analysis, S. G. R. S. College of Pharmacy, Saswad, Pune. (MS), 412301, 
2





Purpose: To develop a simple, rapid and selective method for the extractive spectrophotometric 
determination of omeprazole using acidic dyes. 
Methods: Extractive spectrophotometric determination of omeprazole was developed using acidic dyes 
- bromophenol blue and orange G - as ion-pairing agents in aqueous medium (pH 7.0 and 6.0, 
respectively). The ion pair chromogen formed, which was extracted with chloroform, was measured 
quantitatively at 408 nm and 508 nm, respectively. The developed method was used to analyse 
commercial omeprazole tablets. 
Results: Using bromophenol blue and orange G dyes, the ion-paired formed obeyed Beer’s law in the 













, respectively, for omeprazole,. The purity of 
omeprazole obtained was 98.1±0.9 and 99.7±0.3, respectively. Standard deviation (S.D.), % relative 
standard deviation (% R.S.D.) and standard error were 0.001 - 0.013, 0.94 - 1.07 % and 4 × 10
-4
, 
respectively. The complexes formed were stable for approx. 3 h.  
Conclusion: Recovery studies gave satisfactory results indicating that none of the major 
additives/excipients interferred with the assay method. Therefore, a simple, rapid and selective method 
was developed for extractive spectrophotometric determination of omeprazole. This method may be 
useful for routine laboratory analysis of omeprazole. 
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INTRODUCTION 
 
Omeprazole (Fig 1) is a member of 
benzimidazole class of drugs. It is an 
important benzimidazole derivative which is 
used in the treatment of gastric and duodenal 
ulcers, and reflux oesophagitis [1]. Its efficacy 
as an antiulcer and antisecretory agent has 
been well established. 
 
 
Fig. 1: Omeprazole 
 
Modern pharmaceutical analysis demands 
separation of the desired component from a 
complex dosage formulation followed by its 
instrumental determination. The importance 
of omeprazole prompted the development of 
many methods for its detection and 
determination. Apart from official methods 
based on UV spectrometry [2,3], visible 
spectrometry [2,3], non-aqueous titrations [2-
3], and TLC [2-5], a variety of analytical 
techniques involving HPTLC [5], HPLC [6], 
electrochemical [7] and polarographic [8,9] 
techniques have been reported in the 
literature. Amongst optical methods for drug 
analysis, visible spectrophotometry seems to 
be the most attractive analytical approach 
because it provides a simple precise and 
accurate measurement of suitable analytes. 
 
Visible spectrophotometric methods used for 
the determination of omeprazole are based 
on extraction of the analyte [10-14] into a 
non-aqueous solvent from a complex dosage 
formulation. A marked advantage of this 
method is that it can be applied to the 
determination of an individual component in 
the presence of routine excipients and filling 
materials. An important advantage of the 
extractive spectrophotometric method is that 
it can be applied to the determination of an 
individual component in the presence of 
routine excipients and filling materials. This 
aspect of spectrophotometric analysis is of 
great interest since it offers distinct 
possibilities for the assay of a particular 
component in a complex dosage formulation. 
 
Survey of the literature revealed that only four 
reagents, viz, suprachen violet 3B (SV 3B), 
tropaeolin ooo (TP ooo), bromocresol green 
(BCG) and azocarmine G (AG) [15], have 
been reported for the extractive 
spectrophotometric determination of 
omeprazole. To the best of our knowledge, 
bromophenol blue and orange G, which are 
economical and easily available dyes, hava 
not been used for the extractive 
spectrophotometric determination of 
omeprazole. 
 
In this study, a method for the determination 
of omeprazole is described. The proposed 
method is based on the formation of an ion 
pair between omeprazole and the acidic 
dyes, bromophenol blue and orange G, in 
aqueous buffers - Clark and Lubs buffer (pH 
7), Walpole buffer (acetic acid + sodium 







UV-Visible spectrophotometer Shimadzu 
(1601-A), fitted with a computer and a 1.0 cm 
matched cell, was used. 
 
Reagents and solutions 
 
All the chemicals used were of analytical 
grade. The solvents were of spectroscopic 
grade and were procured from Research 
Laboratories, Pune, India. Aqueous 
bromophenol blue (100 µg/ml) and orange G 
(100 µg/ml) solution were used. 
 
The buffers used were: Sorenson buffer 
(disodium hydrogen citrate + sodium 
hydroxide, pH range 4.96 – 6.33), Walpole 
buffer (acetic acid + sodium acetate, pH 
range 3.72 – 5.57) and Clark and Lubs buffer 
(potassium dihydrogen phosphate + sodium 
hydroxide, pH range 5.8 – 8.0).            
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A stock solution of omeprazole (Torrent 
Pharmaceuticals, Ahmedabad) was prepared 
in 0.05M HCl (100 mg of the drug in 100 ml). 
Working solutions of the drug were prepared 
by dilution of the stock solution. The 
marketed capsule of omeprazole used in the 
determination was Pirazole
®
 with a labeled 
strength of 20 mg and manufactured by 
Nicholas Piramal India Limited, Parel, 
Mumbai, India. 
 
Optimisation of experimental conditions 
 
While studying the effect of pH, the drug-dye 
ion-pair formation was found to be critically 
dependent on the pH of the aqueous phase; 
at pH values higher than 7.5, no ion-pair was 
formed. In this method, the ion-pairs formed 
with bromophenol blue (BPB) and orange G 
at pH 6.0 and 7.0 were extracted into 
chloroform and the absorbance was 
measured at 408 nm and 503 nm, 
respectively. 
 
Prior to this experiment, several organic 
solvents such as benzene, toluene, 
cyclohexane, carbon tetrachloride, in addition 
to chloroform, were examined for their ability 
to extract the drug-dye ion-pair. Chloroform 
was found to be the most suitable solvent in 
terms of extraction efficiency and hence, it 
was used in this experiment. 
 
Optimum conditions for quantitative 
extraction of the drug-dye ion-pair were also 
investigated. For omeprazole-BPB and 
omeprazole-orange G ion-pairs, the 
absorbances were maximal and constant 
over the pH range 6.6 - 7.4 and 5.8 - 6.2, 
respectively; hence, pH 7.0 and 6.0, 
respectively, were selected for the study and 
Clark and Lubs buffer and Sorenson buffer 
were used in the determinations. These 
buffers were found to provide appropriate 
media for efficient extraction. A single 
extraction with chloroform and 5 ml of buffer 
was found to be adequate for the 
concentration range investigated. Shaking 
times, ranging from 0.5 to 3.0 min, produced 
no change in absorbance; therefore, a 1 min 
shaking time was selected. The absorbance 
of the chloroform phase was found to be 
stable for 2-3 h. Absorbance was measured 
periodically at an interval of 15 min for 3 h. 
The colour intensity of the organic layer had 
shown a very gradual increase during the first 
hour but subsequently became stable for 2-3 
h. 
 
The experiments were repeated with varying 
concentrations of dye in the range 0.01 mg to 
0.2 mg per ml. The dye concentration of 0.1 
mg per ml was found to give maximal 
absorbance. 
 
Preparation of calibration curve  
 
Standard solutions of omeprazole in 0.05M 
HCl, having final concentrations in the range 
0.01 mg per 2 ml to 0.06 mg per 2 ml, were 
taken in separatory funnels. To each 
separatory funnel, 2 ml of dye solution (0.1 
mg per ml), 2 ml buffer solution of pH 7 and 5 
ml chloroform were added, and the mixtures 
were thoroughly shaken. The organic layer 
was allowed to separate and then collected in 
a dry test tube. The absorbance of each 
chloroform extract was measured at 408 nm 
against a blank similarly prepared by 
replacing drug solution with 0.05M HCl.  
 
Assay of a commercial pharmaceutical 
preparation 
 
Standard solutions of pure omeprazole of 10 
and 150 µg/ml for bromophenol blue dye and 
orange G dye, respectively) were prepared. 
 
Twenty capsules were weighed and their 
contents mixed thoroughly. An accurately 
weighed portion of the powder equivalent to 
the labelled strength (20mg) of the 
omeprazole capsules was dissolved in 10 ml 
of 0.05M HCl and filtered through a Whatman 
filter paper no. 2. The filtrate was transferred 
to a volumetric flask containing 0.05M HCl. 
An aliquot of this solution was diluted with 
0.05M HCl to obtain a concentration of 10 
µg/ml for bromophenol blue dye and 150 
µg/ml for orange G dye. 
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General procedure 
 
Several standard solutions of omeprazole in 
0.05M HCl were taken in individual 
separatory funnels. To each separatory 
funnel, 2 ml of dye solution (0.1 mg/ml), 2 ml 
buffer solution and 5 ml chloroform were 
added and the mixtures were thoroughly 
shaken. The chloroform layers were allowed 
to separate, collected in separate dry test 
tubes and the absorbance was measured at 
λ max 408nm and 503nm for omeprazole-
BPB complex and omeprazole-orange-G 
complex, respectively, against a blank 
similarly prepared by replacing drug solution 
with 0.05M HCl. The concentration of 
omeprazole in each test tube was obtained 
by interpolating the corresponding 
absorbance value from Beer’s plot of 






An accurately weighed quantity of 
omeprazole, equivalent to about 50 mg, was 
dissolved in 10 ml of 0.05M HCl and diluted 
to 50 ml with the same medium. It was then 




An accurately weighed quantity of the 
capsule contents, equivalent to about 50 mg, 
was transferred to 50 ml volumetric flask and 
about 50 mg of accurately weighed 
omeprazole powder was added to it. The 
mixed contents were dissolved in 0.05M HCl. 
The solution was filtered and the final volume 
was made to 50 ml with the same medium. 
The solution was further diluted to a 
concentration of 20 µg/ml. 
 
Determination of omeprazole content 
 
From absorbance values, concentration of 
the reference and the test samples were 
calculated, and the  omeprazole content was 
calculated as in Eq. 1 
Weight (Q) = concentration x dilution factor ….(1) 
 
The weight of omeprazole contributed by 
capsule powder (Q) was deducted from total 
omeprazole and the amount of drug after 
deduction was assumed to be recovered from 
the added quantity of omeprazole. From the 
weight of omeprazole in standard and test 
sample, recovery (R) was calculated using 
the standard IUPAC formula provided -                          
 
R (%) = Qsample – Qstandard / Qstandard  x 100 .........(2) 
                               
RESULTS   
 
The factors affecting color development, 
reproducibility, sensitivity and adherence to 
Beer’s law were analysed from the data. 
Beer’s law limit, molar absorptivity, 
regression data, correlation coefficient and 
precision data for the various omeprazole 
preparations are given in Table 1.  
 
Table 1: Optical characteristics of omeprazole 
complexes 
 
Parameter   
Omeprazole 




λ max (nm)  408 503 
Stability (h)                             3 3 






)                 
1.712×10
3 
                                   2.0954×10
3
 
Regression data   
 
Slope (a) 0.005 0.0064 
Intercept (b) -0.0003 -0.039 
Correlation 




 1.0669 0.93776    
 
a
Number of independent analyses, n =5. 
The regression equation and regression coefficient 
for omeprazole-BPB complex are  
Y = 0.005X – 0.0003 and 0.9986, while for 
omeprazole-orange-G complex, they are  
Y = 0.0064X – 0.039 and 0.9984, respectively. 
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Table 2: Determination of omeprazole in commercial preparation                                               
 
Preparation     Label claim     Proposed       Analyte         Recovery               Official method           
(mg/capsule)    method             added             (%)
a 
              (found %)
a                    
(USP 24) 
                                                (found %)
a 
     (mg)
b
     
                       
BPB
 c
                 10                   98.1±0.9           10                  100.7±0.7             100±1 
Orange G           10                   99.7±0.3           10                   98.0±0.7              100±1      
 
a
Mean ± SD (n = 5); 
b




As the results in Table 2 show, the developed 
method compared favorably with those 




Ion-pair extractive spectrometry has attracted 
considerable attention for quantitative 
analyses of many pharmaceutically active 
compounds. In the present investigation, 
bromophenol blue (BPB) and orange G, 
being anionic dyes, formed a coloured ion-
pair with omeprazole at pH 7 and 6 
respectively; each of the chromogen formed 
was soluble in chloroform and their 
absorbances were measurable at 408 and 
503 nm, respectively. 
 
Optimisation of the spectrophotometric condi-
tions were intended to take into account the 
various goals of method development and to 
weigh each goal accurately. Analytical 
conditions were optimised via a number of 
preliminary experiments. Among various 
organic solvents studied - carbon 
tetrachloride, benzene and chloroform - 
chloroform was preferred because of its more 
efficient extraction of the drug-dye ion-pair 
from the aqueous phase. Only one extraction 
was sufficient to achieve quantitative 
recovery of the complex. Shaking times 
ranging from 0.5 to 3 min produced no 
change in absorbance, and so a one min 
shaking time was selected. The absorbance 
of the chloroform phase was stable for 2 - 3 
h. The absorbance was measured 
periodically at an interval of 15 min for 3 h. 
The colour intensity of the organic layer 
showed a gradual increase during the 1st 
hour but subsequently became stable for 2 - 
3 h. The experiments were repeated with 
varying concentrations of dye in the range 
0.01 mg to 0.2 mg per ml of dye solution but 
the dye concentration of 0.1 mg/ml was found 
to give maximal absorbance for both dyes.  
The effect of pH was studied by extracting 
the coloured complex in the presence of 
various buffers of different acidic pH values. 
Buffers of pH 7 and 6 and bromophenol blue 
(0.1 mg/ml) and orange G (also 0.1 mg/ml) 
solutions, respectively, were the most 
suitable for quantitative formation of ion-pair. 
Being basic in nature, omeprazole formed 
ion-pairs with the acidic dyes, which are 
extractable into chloroform from the aqueous 
phase at the pH values provide optimal 




Omeprazole was estimated successfully by 
the developed extractive spectrophotometric 
method, both as a pure compound, and as a 
constituent of a capsule formulation. The 
method is simple, rapid, accurate, and does 
not involve any critical reaction conditions, or 
tedious sample preparation. It is unaffected 
by slight variations in experimental conditions 
such as pH, dye concentration, shaking time 
and temperature. The applicability of the new 
procedure for routine quality control of 
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